- Home
- IZM vs PULM Comparison
IZM vs PULM Comparison
Compare IZM & PULM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IZM | PULM |
|---|---|---|
| Founded | 2011 | 2003 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Consumer Electronics/Video Chains | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.8M | 13.6M |
| IPO Year | 2023 | N/A |
Fundamental Metrics
Financial Performance| Metric | IZM | PULM |
|---|---|---|
| Price | $1.37 | $2.67 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 95.8K | 18.8K |
| Earning Date | 10-24-2025 | 10-16-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.10 | N/A |
| Revenue | ★ $187,048,691.00 | $3,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $134.88 |
| P/E Ratio | $13.60 | ★ N/A |
| Revenue Growth | ★ 5.12 | N/A |
| 52 Week Low | $0.87 | $2.15 |
| 52 Week High | $2.74 | $10.40 |
Technical Indicators
Market Signals| Indicator | IZM | PULM |
|---|---|---|
| Relative Strength Index (RSI) | 42.49 | 46.04 |
| Support Level | $1.30 | $2.47 |
| Resistance Level | $1.49 | $2.86 |
| Average True Range (ATR) | 0.21 | 0.21 |
| MACD | -0.07 | 0.10 |
| Stochastic Oscillator | 5.24 | 60.30 |
Price Performance
Historical ComparisonAbout IZM ICZOOM Group Inc.
ICZOOM Group Inc. operates an e-commerce platform selling electronic components to SMEs in China across consumer electronics, IoT, automotive, and industrial control sectors. It offers two main product categories: semiconductor products, including integrated circuits and optoelectronics, and electronic equipment and tools such as electromechanical and MRO supplies. The company also provides services like customs clearance, temporary warehousing, and logistics, earning additional commission fees. The majority of its revenue comes from electronic component sales.
About PULM Pulmatrix Inc.
Pulmatrix Inc is a biopharmaceutical company that has focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).